Medline Inc. (MDLN) Gross Margin
- Gross margin · 12 months: Value 26.20%; Formula and calculation Gross profit / revenue. Period ending 2026-06-27..
Gross margin
Overview →Financial period ending 2026-06-27; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 26.20% | Gross profit / revenue. Period ending 2026-06-27. $7.84B ÷ $29.94B × 100 ≈ 26.20% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 7.84B USD | Gross Profit |
| Revenue | 29.94B USD | |
| Cost of products and services | 22.09B USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-27 | $7.84B | $29.94B | $22.09B | 26.20% |
| 2026-03-28 | $7.54B | $29.14B | $21.61B | 25.86% |
| 2025-12-31 | $7.52B | $28.43B | $20.91B | 26.44% |
| 2025-06-28 | (m) | (m) | (m) | (m) |
| 2025-03-29 | (m) | (m) | (m) | (m) |
| 2024-12-31 | $6.98B | $25.51B | $18.53B | 27.35% |
| 2023-12-31 | $5.88B | $23.23B | $17.35B | 25.33% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.